Records containing: Ovarian Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-05-27A Phase I Open Label Assessment of the Safety and Pharmacokinetics of Intraperitoneal PACLIMER Microspheres (Polilactofate/Paclitaxel) in Patients With Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-05-27Evaluation of Gemcitabine and Cisplatin in Recurrent, Platinum Resistant and Refractory Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-05-27A Phase I Study of Sequential Prolonged Oral Topotecan (IND# 58,131) and Prolonged Oral Etoposide as Second Line Therapy in Ovarian, Peritoneal or Tubal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-05-27A Phase I Study of Paclitaxel, Carboplatin, and Increasing Doses of Doxil in Untreated Ovarian, Peritoneal, and Tubal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-05-27A Phase III Randomized Trial of Intravenous Paclitaxel and Cisplatin Versus Intravenous Paclitaxel, Intraperitoneal Cisplatin and Intraperitoneal Paclitaxel in Patients With Optimal Stage III Epithelial Ovarian Carcinoma or Primary Peritoneal Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-05-21Bevacizumab Combined With High-Dose Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Patients With Advanced Epithelial Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-05-16A Phase II Evaluation of Abraxane Plus Bevacizumab for the Treatment of Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2013-05-14A Phase 1 Open-Label Study of the Safety and Feasibility of ZYC300 Administration With Cyclophosphamide Pre-Dosing
-
CLINICAL_TRIALS study record update · 2013-05-13An Open-Label, Randomised Study of Multi-Cycle, Dose Intensive Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
-
CLINICAL_TRIALS study record update · 2013-05-13The Validation of Two Inpatient Adult Nutrition Screening Tools in Cancer Care - a Prospective Study
-
CLINICAL_TRIALS study record update · 2013-05-07Distinction Between Lung Cancer and Gynecological Cancers by Exhalation Analysis and Canine Scent Detection
-
CLINICAL_TRIALS study record update · 2013-04-26Phase I/II Study of Escalating Dose Melphalan With Autologous Pluripotent Hematopoietic Stem Cell Support and Amifostine Cytoprotection in Cancer Patients
-
CLINICAL_TRIALS study record update · 2013-04-18Urine Prostaglandin-M(PGE-M) in Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2013-04-17A Phase II Trial Using Multiple Cycles of High Dose Sequential Carboplatin, Paclitaxel and Topotecan With Peripheral Blood Stem Cell (PBSC) Support as Initial Chemotherapy in Patients With Suboptimally Debulked Stage III or IV Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-04-11A Phase II Evaluation of Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum and Paclitaxel-Resistant Ovarian or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2013-04-11Treatment of Ovarian Carcinoma With DNP-Modified Autologous Tumor Vaccine
-
CLINICAL_TRIALS study record update · 2013-04-11A RANDOMIZED, CONTROLLED TRIAL OF SALVAGE THERAPY WITH PACLITAXEL AND CARBOPLATIN VERSU SALVAGE THERAPY WITH STEM CELL SUPPORTED HIGH-DOSE CARBOPLATIN, MITOXANTRONE AND CYCLOPHOSPHAMIDE IN PATIENTS WITH PERSISTENT LOW VOLUME OVARIAN CANCER AND RESPONSE TO PRIMARY THERAPY
-
CLINICAL_TRIALS study record update · 2013-04-11Evaluation of Docetaxel in Recurrent, Platinum Resistant, Refractory and Paclitaxel Refractory Ovarian Cancer and Primary Peritoneal Carcinoma
-
CLINICAL_TRIALS study record update · 2013-04-11Phase II Evaluation Of Capecitabine In Recurrent Platinum-Sensitive Ovarian Or Primary Peritoneal Cancer
-
CLINICAL_TRIALS study record update · 2013-04-11A Limited Access Trial Using Amifostine for Protection Against Cisplatin and 3-Hour Paclitaxel-Induced Neurotoxicity
-
CLINICAL_TRIALS study record update · 2013-04-05A Phase I Study of Weekly Oral Topotecan in Gynecologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-03-28A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian
-
CLINICAL_TRIALS study record update · 2013-03-26Cytokine-Based Immunotherapy Following High-Dose Chemotherapy and Autologous Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-03-11Phase II Randomised, Double Blind, Multicentre Study to Assess the Efficacy of AZD2281 in the Treatment of Patients With Platinum Sensitive Relapsed Serous Ovarian Cancer Following Treatment With Two or More Platinum Containing Regimens
-
CLINICAL_TRIALS study record update · 2013-03-07A Phase II Trial of Gemcitabine and Docetaxel in Patients With Unresectable Leiomyosarcoma